FDA lifts clinical hold on studies of LentiGlobin in sickle cell disease and beta-thalassemia June 8, 2021
Selpercatinib shows promising safety and efficacy in RET-altered solid tumors in pediatric patients June 8, 2021
First patient dosed in phase II study of CRS-3123 to treat Clostridioides difficile infection June 8, 2021
StemVacs-V iPSC amplifies cancer-specific immune response and shows synergy with other therapies June 8, 2021
RSS